Carbon monoxide: A critical quantitative analysis and review of the extent and limitations of its second messenger function

Clinical Pharmacology: Advances and Applications

Volumn 7, Issue , 2015, Pages 37-56

  Levitt, David G ^a   Levitt, Michael D ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cytochrome; Heme; Krogh cylinder model; Oxygenase; ROS

Indexed keywords

CALCIUM CHANNEL; CARBON MONOXIDE; CARBON MONOXIDE OXIDATION ACTIVATOR; CYTOCHROME C OXIDASE; CYTOCHROME P450; EPITHELIAL SODIUM CHANNEL; GUANYLATE CYCLASE; HEME OXYGENASE; HEMOGLOBIN; MYOGLOBIN; REACTIVE OXYGEN METABOLITE; REGULATOR PROTEIN; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

BINDING AFFINITY; BLOOD CARBON MONOXIDE TENSION; BLOOD GAS TENSION; BLOOD OXYGEN TENSION; CATABOLISM; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ENZYME SUBSTRATE; ERYTHROCYTE GAS TRANSPORT; ERYTHROCYTE SEDIMENTATION RATE; HEME SYNTHESIS; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; OXYGEN TRANSPORT; PLASMA PROTEIN BINDING; QUANTITATIVE ANALYSIS; REVIEW; SECOND MESSENGER; STEADY STATE;

EID: 84930942746     PISSN: None     EISSN: 11791438     Source Type: Journal    
DOI: 10.2147/CPAA.S79626     Document Type: Review

References (116)

1. Bernard C. Lecons sur les effects des substances toxiques et medicamenteuses. Paris: Bailliere; 1857. French.
2. Sjostrand T. The formation of carbon monoxide by the decomposition of haemoglobin in vivo. Acta Physiol Scand. 1952;26(4):338–344.
3. Ghosh D, LeVault KR, Brewer GJ. Dual-energy precursor and nuclear erythroid-related factor 2 activator treatment additively improve redox glutathione levels and neuron survival in aging and Alzheimer mouse neurons upstream of reactive oxygen species. Neurobiol Aging. 2014;35(1):179–190.
4. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol. 1997;37:517–554.
5. Wu L, Wang R. Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev. 2005;57(4):585–630.
6. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev. 2006;86(2):583–650.
7. Gozzelino R, Jeney V, Soares MP. Mechanisms of cell protection by heme oxygenase-1. Annual review of pharmacology and toxicology. 2010;50:323–354.
8. Queiroga CS, Vercelli A, Vieira HL. Carbon monoxide and the CNS: challenges and achievements. Br J Pharmacol. Epub April 24, 2014.
9. Gullotta F, di Masi A, Coletta M, Ascenzi P. CO metabolism, sensing, and signaling. Biofactors. 2012;38(1):1–13.
10. Heinemann SH, Hoshi T, Westerhausen M, Schiller A. Carbon monoxide – physiology, detection and controlled release. Chem Commun (Camb). 2014;50(28):3644–3660.
11. Leffler CW, Parfenova H, Jaggar JH. Carbon monoxide as an endogenous vascular modulator. Am J Physiol Heart Circ Physiol. 2011;301(1):H1–H11.
12. Maines MD, Gibbs PE. 30 some years of heme oxygenase: from a “molecular wrecking ball” to a “mesmerizing” trigger of cellular events. Biochem Biophys Res Commun. 2005;338(1):568–577.
13. Hanafy KA, Oh J, Otterbein LE. Carbon monoxide and the brain: time to rethink the dogma. Curr Pharm Des. 2013;19(15):2771–2775.
14. Agostoni A, Stabilini R, Viggiano G, Luzzana M, Samaja M. Influence of capillary and tissue PO2 on carbon monoxide binding to myoglobin: a theoretical evaluation. Microvasc Res. 1980;20(1): 81–87.
15. Roughton FJW, DeLand EC, Kernohan JC, Serveringhaus JW. Some recent studies of the oxyhaemoglobin dissociation curve of human blood under physiological conditions and the fitting of the Adair equation to the standard curve. Paper presented at: Proceeding of the Alfred Benzon Symposium IV; 1972; Copenhagen, Denmark.
16. Roughton FJ. The equilibrium of carbon monoxide with human hemoglobin in whole blood. Ann N Y Acad Sci. 1970;174(1):177–188.
17. Furne JK, Springfield JR, Ho SB, Levitt MD. Simplification of the end-alveolar carbon monoxide technique to assess erythrocyte survival. J Lab Clin Med. 2003;142(1):52–57.
18. Coburn RF, Forster RE, Kane PB. Considerations of the physiological variables that determine the blood carboxyhemoglobin concentration in man. J Clin Invest. 1965;44(11):1899–1910.
19. Peterson JE, Stewart RD. Absorption and elimination of carbon monoxide by inactive young men. Arch Environ Health. 1970;21(2):165–171.
20. Drabkin DL. The distribution of the chromoprotein, hemoglobin, myoglobin, and cytochrome c, in the tissues of different species and the relationship of the total content of each chromoprotein to body mass. J Biol Chem. 1950;1950(182):317–334.
21. Bruce EN, Bruce MC. A multicompartment model of carboxyhemoglobin and carboxymyoglobin responses to inhalation of carbon monoxide. J Appl Physiol (1985). 2003;95(3):1235–1247.
22. Riches AC, Sharp JG, Thomas DB, Smith SV. Blood volume determination in the mouse. J Physiol. 1973;228(2):279–284.
23. Guyton AC. Measurement of the respiratory volumes of laboratory animals. Am J Physiol. 1947;150(1):70–77.
24. Verma K, Penney DG, Helfman CC, Sutariya BB. Carboxyhemoglobin in the rat: improvements in the spectrophotometric measurement and comparison to other studies. J Appl Toxicol. 1989;9(5):323–330.
25. Reedy CJ, Elvekrog MM, Gibney BR. Development of a heme protein structure-electrochemical function database. Nucleic Acids Res. 2008;36(Database issue):D307–D313.
26. Piantadosi CA. Biological chemistry of carbon monoxide. Antioxidant Redox Signal. 2002;4(2):259–270.
27. Alonso JR, Cardellach F, López S, Casademont J, Miró O. Carbon monoxide specifically inhibits cytochrome c oxidase of human mitochondrial respiratory chain. Pharmacol Toxicol. 2003;93(3):142–146.
28. Zuckerbraun BS, Chin BY, Bilban M, et al. Carbon monoxide signals via inhibition of cytochrome c oxidase and generation of mitochondrial reactive oxygen species. FASEB J. 2007;21(4):1099–1106.
29. Petersen LC. The effect of inhibitors on the oxygen kinetics of cytochrome c oxidase. Biochim Biophys Acta. 1977;460(2):299–307.
30. Hansen FB, Nicholls P. Control of respiration in proteoliposomes containing cytochrome aa3. II. Inhibition by carbon monoxide and azide. Biochim Biophys Acta. 1978;502(3):400–408.
31. Yoshikawa S, Choc MG, O’Toole MC, Caughey WS. An infrared study of CO binding to heart cytochrome c oxidase and hemoglobin A. Implications re O2 reactions. J Biol Chem. 1977;252(15): 5498–5508.
32. Wohlrab H, Ogunmola GB. Carbon monoxide binding studies of cytochrome a3 hemes in intact rat liver mitochondria. Biochemistry. 1971;10(7):1103–1106.
33. Gnaiger E, Lassnig B, Kuznetsov A, Rieger G, Margreiter R. Mitochondrial oxygen affinity, respiratory flux control and excess capacity of cytochrome c oxidase. J Exp Biol. 1998;201(Pt 8):1129–1139.
34. Wilson DF, Rumsey WL, Green TJ, Vanderkooi JM. The oxygen dependence of mitochondrial oxidative phosphorylation measured by a new optical method for measuring oxygen concentration. J Biol Chem. 1988;263(6):2712–2718.
35. Coburn RF. Mechanisms of carbon monoxide toxicity. Prev Med. 1979;8(3):310–322.
36. Glabe A, Chung Y, Xu D, Jue T. Carbon monoxide inhibition of regulatory pathways in myocardium. Am J Physiol. 1998;274(6 Pt 2): H2143–H2151.
37. Chance B, Erecinska M, Wagner M. Mitochondrial responses to carbon monoxide toxicity. Ann N Y Acad Sci. 1970;174(1):193–204.
38. Cooper CE, Brown GC. The inhibition of mitochondrial cytochrome oxidase by the gases carbon monoxide, nitric oxide, hydrogen cyanide and hydrogen sulfide: chemical mechanism and physiological significance. J Bioenerg Biomembr. 2008;40(5):533–539.
39. McLennan HR, Degli Esposti M. The contribution of mitochondrial respiratory complexes to the production of reactive oxygen species. J Bioenerg Biomembr. 2000;32(2):153–162.
40. Mittler R, Vanderauwera S, Suzuki N, et al. ROS signaling: the new wave? Trends Plant Sci. 2011;16(6):300–309.
41. Sena LA, Chandel NS. Physiological roles of mitochondrial reactive oxygen species. Molecular cell. 2012;48(2):158–167.
42. Thom SR, Fisher D, Xu YA, Notarfrancesco K, Ischiropoulos H. Adaptive responses and apoptosis in endothelial cells exposed to carbon monoxide. Proc Natl Acad Sci U S A. 2000;97(3):1305–1310.
43. Middleton ET, Morice AH. Breath carbon monoxide as an indication of smoking habit. Chest. 2000;117(3):758–763.
44. Peng CA, Palsson BO. Determination of specific oxygen uptake rates in human hematopoietic cultures and implications for bioreactor design. Ann Biomed Eng. 1996;24(3):373–381.
45. Zhang X, Shan P, Otterbein LE, et al. Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase 3. J Biol Chem. 2003;278(2):1248–1258.
46. Ryter SW, Morse D, Choi AM. Carbon monoxide: to boldly go where NO has gone before. Sci STKE. 2004;2004(230):RE6.
47. Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH. Carbon monoxide: a putative neural messenger. Science. 1993;259(5093):381–384.
48. Stone JR, Marletta MA. Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry. 1994;33(18):5636–5640.
49. Ingi T, Chiang G, Ronnett GV. The regulation of heme turnover and carbon monoxide biosynthesis in cultured primary rat olfactory receptor neurons. J Neurosci. 1996;16(18):5621–5628.
50. Cary SP, Marletta MA. The case of CO signaling: why the jury is still out. J Clin Invest. 2001;107(9):1071–1073.
51. Aono S. Biochemical and biophysical properties of the CO-sensing transcriptional activator CooA. Acc Chem Res. 2003;36(11):825–831.
52. Uchida T, Sato E, Sato A, Sagami I, Shimizu T, Kitagawa T. CO-dependent activity-controlling mechanism of heme-containing CO-sensor protein, neuronal PAS domain protein 2. J Biol Chem. 2005;280(22):21358–21368.
53. Gilun P, Stefanczyk-Krzymowska S, Romerowicz-Misielak M, Tabecka-Lonczynska A, Przekop F, Koziorowski M. Carbon monoxide-mediated humoral pathway for the transmission of light signal to the hypothalamus. J Physiol Pharmacol. 2013;64(6):761–772.
54. Dioum EM, Rutter J, Tuckerman JR, Gonzalez G, Gilles-Gonzalez MA, McKnight SL. NPAS2: a gas-responsive transcription factor. Science. 2002;298(5602):2385–2387.
55. Artinian LR, Ding JM, Gillette MU. Carbon monoxide and nitric oxide: interacting messengers in muscarinic signaling to the brain’s circadian clock. Exp Neurol. 2001;171(2):293–300.
56. Puranik M, Nielsen SB, Youn H, et al. Dynamics of carbon monoxide binding to CooA. J Biol Chem. 2004;279(20):21096–21108.
57. Vetri F, Choudhury MSR, Pelligrino DA, Sundivakkam P. BKCa channels as physiological regulators: a focused review. J Receptor Ligand Channel Res. 2014;7:3–13.
58. Hou S, Xu R, Heinemann SH, Hoshi T. The RCK1 high-affinity Ca2+ sensor confers carbon monoxide sensitivity to Slo1 BK channels. Proc Natl Acad Sci U S A.. 2008;105(10):4039–4043.
59. Xi Q, Tcheranova D, Parfenova H, Horowitz B, Leffler CW, Jaggar JH. Carbon monoxide activates KCa channels in newborn arteriole smooth muscle cells by increasing apparent Ca2+ sensitivity of alpha-subunits. Am J Physiol Heart Circ Physiol. 2004;286(2):H610–H618.
60. Knecht KR, Milam S, Wilkinson DA, Fedinec AL, Leffler CW. Time-dependent action of carbon monoxide on the newborn cerebrovascular circulation. Am J Physiol Heart Circ Physiol. 2010;299(1):H70–H75.
61. Holt DC, Fedinec AL, Vaughn AN, Leffler CW. Age and species dependence of pial arteriolar responses to topical carbon monoxide in vivo. Exp Biol Med (Maywood). 2007;232(11):1465–1469.
62. Wang R, Wang Z, Wu L. Carbon monoxide-induced vasorelaxation and the underlying mechanisms. Br J Pharmacol. 1997;121(5):927–934.
63. Morita T, Perrella MA, Lee ME, Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci U S A. 1995;92(5):1475–1479.
64. Yi L, Morgan JT, Ragsdale SW. Identification of a thiol/disulfide redox switch in the human BK channel that controls its affinity for heme and CO. J Biol Chem. 2010;285(26):20117–20127.
65. Wu JY, Qu HY, Shang ZL, et al. Reciprocal regulation of Ca(2)+-activated outward K+ channels of Pyrus pyrifolia pollen by heme and carbon monoxide. New Phytol. 2011;189(4):1060–1068.
66. Williams SE, Wootton P, Mason HS, et al. Hemoxygenase-2 is an oxygen sensor for a calcium-sensitive potassium channel. Science. 2004;306(5704):2093–2097.
67. Migita CT, Matera KM, Ikeda-Saito M, et al. The oxygen and carbon monoxide reactions of heme oxygenase. J Biol Chem. 1998;273(2):945–949.
68. Altman PL, Dittmer DS. Respiration and circulation. Bethesda, MD: Federation of American Societies for Experimental Etiology; 1971:16. http://www2.epa.gov/sites/production/files/2014-03/documents/leidyref.pdf.
69. Ortega-Sáenz P, Pascual A, Piruat JI, López-Barneo J. Mechanisms of acute oxygen sensing by the carotid body: lessons from genetically modified animals. Respir Physiol Neurobiol. 2007;157(1):140–147.
70. Wang S, Publicover S, Gu Y. An oxygen-sensitive mechanism in regulation of epithelial sodium channel. Proc Natl Acad Sci U S A. 2009;106(8):2957–2962.
71. Otterbein LE, Mantell LL, Choi AM. Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol. 1999;276(4 Pt 1): L688–L694.
72. Althaus M, Fronius M, Buchackert Y, et al. Carbon monoxide rapidly impairs alveolar fluid clearance by inhibiting epithelial sodium channels. Am J Respir Cell Mol Biol. 2009;41(6):639–650.
73. Wilkinson WJ, Kemp PJ. Carbon monoxide: an emerging regulator of ion channels. J Physiol. 2011;589(Pt 13):3055–3062.
74. Motterlini R. Carbon monoxide-releasing molecules (CO-RMs): vasodilatory, anti-ischaemic and anti-inflammatory activities. Biochem Soc Trans. 2007;35(Pt 5):1142–1146.
75. Motterlini R, Otterbein LE. The therapeutic potential of carbon monoxide. Nat Rev Drug Discov. 2010;9(9):728–743.
76. Scragg JL, Dallas ML, Wilkinson JA, Varadi G, Peers C. Carbon monoxide inhibits L-type Ca2+ channels via redox modulation of key cysteine residues by mitochondrial reactive oxygen species. J Biol Chem. 2008;283(36):24412–24419.
77. Dallas ML, Boyle JP, Milligan CJ, et al. Carbon monoxide protects against oxidant-induced apoptosis via inhibition of Kv2.1. FASEB J. 2011;25(5):1519–1530.
78. Nielsen VG, Pearson EC, Smith MC. Increased carbon monoxide production by hemeoxygenase-1 caused by device-mediated hemolysis: thrombotic phantom menace? Artif Organs. 2013;37(11):1008–1014.
79. Arkebauer MR, Kanaparthy SS, Malayaman SN, Vosseller K, Nielsen VG. Carbon monoxide and nitric oxide modulate α-antiplasmin and plasmin activity: role of heme. Blood Coagul Fibrinolysis. 2011;22(8):712–719.
80. Nielsen VG, Cohen JB, Malayaman SN, Nowak M, Vosseller K. Fibrinogen is a heme-associated, carbon monoxide sensing molecule: a preliminary report. Blood Coagul Fibrinolysis. 2011;22(5):443–447.
81. Berk PD, Howe RB, Bloomer JR, Berlin NI. Studies of bilirubin kinetics in normal adults. J Clin Invest. 1969;48(11):2176–2190.
82. Blanckaert N, Fevery J. Physiology and pathophysiology of bilirubin metabolism. In: Zakim D, Boyer TD, editors. Hepatology: A textbook of Liver Disease. Volume 1. 2nd ed. Philadelphia: WB Saunders; 1990:254–302.
83. Dickerson JW, Widdowson EM. Chemical changes in skeletal muscle during development. Biochem J. 1960;74:247–257.
84. Kagen LJ, Christian CL. Immunologic measurements of myoglobin in human adult and fetal skeletal muscle. Am J Physiol. 1966;211(3):656–660.
85. Vreman HJ, Stevenson DK. Heme oxygenase activity as measured by carbon monoxide production. Anal Biochem. 1988;168(1):31–38.
86. Ishikawa K, Navab M, Leitinger N, Fogelman AM, Lusis AJ. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J Clin Invest. 1997;100(5):1209–1216.
87. Ponka P. Cell biology of heme. Am J Med Sci. 1999;318(4):241–256.
88. Zheng J, Tian Q, Hou W, Watts JA, Schrum LW, Bonkovsky HL. Tissue-specific expression of ALA synthase-1 and heme oxygenase-1 and their expression in livers of rats chronically exposed to ethanol. FEBS Lett. 2008;582(13):1829–1834.
89. Berk PD, Bloomer JR, Howe RB, Blaschke TF, Berlin NI. Bilirubin production as a measure of red cell life span. J Lab Clin Med. 1972; 79(3):364–378.
90. Ajioka RS, Phillips JD, Kushner JP. Biosynthesis of heme in mammals. Biochim Biophys Acta. 2006;1763(7):723–736.
91. Balaban RS, Mootha VK, Arai A. Spectroscopic determination of cytochrome c oxidase content in tissues containing myoglobin or hemoglobin. Anal Biochem. 1996;237(2):274–278.
92. Qiu Y, Sutton L, Riggs AF. Identification of myoglobin in human smooth muscle. J Biol Chem. 1998;273(36):23426–23432.
93. Leffler CW, Parfenova H, Fedinec AL, Basuroy S, Tcheranova D. Contributions of astrocytes and CO to pial arteriolar dilation to glutamate in newborn pigs. Am J Physiol Heart Circ Physiol. 2006;291(6): H2897–H2904.
94. Zahs KR, Wu T. Confocal microscopic study of glial-vascular relationships in the retinas of pigmented rats. J Comp Neurol. 2001;429(2):253–269.
95. Krogh A. The number and distribution of capillaries in muscles with calculations of the oxygen pressure head necessary for supplying the tissue. J Physiol. 1919;52(6):409–415.
96. Hart MN, Heistad DD, Brody MJ. Effect of chronic hypertension and sympathetic denervation on wall/lumen ratio of cerebral vessels. Hypertension. 1980;2(4):419–423.
97. Staszyk C, Bohnet W, Gasse H, Hackbarth H. Blood vessels of the rat tail: a histological re-examination with respect to blood vessel puncture methods. Lab Anim. 2003;37(2):121–125.
98. Heistad DD, Marcus ML. Role of vasa vasorum in nourishment of the aorta. Blood Vessels. 1979;16(5):225–238.
99. Wolinsky H, Glagov S. Nature of species differences in the medial distribution of aortic vasa vasorum in mammals. Circ Res. 1967;20(4):409–421.
100. Cussler EL. Diffusion – Mass Transfer in Fluid Systems. 2nd ed. Cambridge: University of Cambridge; 1997.
101. Lenzi GL, Frackowiak RS, Jones T, et al. CMRO2 and CBF by the oxygen-15 inhalation technique. Results in normal volunteers and cerebrovascular patients. Eur Neurol. 1981;20(3):285–290.
102. Kanu A, Whitfield J, Leffler CW. Carbon monoxide contributes to hypotension-induced cerebrovascular vasodilation in piglets. Am J Physiol Heart Circ Physiol. 2006;291(5):H2409–H2414.
103. Beckman JD, Belcher JD, Vineyard JV, et al. Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell disease. Am J Physiol Heart Circ Physiol. 2009;297(4):H1243–H1253.
104. Wegiel B, Gallo D, Csizmadia E, et al. Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth. Cancer Res. 2013;73(23):7009–7021.
105. Zuckerbraun BS, Chin BY, Wegiel B, et al. Carbon monoxide reverses established pulmonary hypertension. J Exp Med. 2006;203(9):2109–2119.
106. Wegiel B, Hedblom A, Li M, et al. Heme oxygenase-1 derived carbon monoxide permits maturation of myeloid cells. Cell Death Dis. 2014;5:e1139.
107. Kuramitsu K, Gallo D, Yoon M, et al. Carbon monoxide enhances early liver regeneration in mice after hepatectomy. Hepatology. 2011;53(6):2016–2026.
108. Wise D, Houghton G. Diffusion coefficients of neon, krypton, xenon, carbon monoxide and nitric oxide in water at 10–60 C. Chem Eng Sci. 1968;23(10):1211–1216.
109. Kawashiro T, Nüsse W, Scheid P. Determination of diffusivity of oxygen and carbon dioxide in respiring tissue: results in rat skeletal muscle. Pflugers Arch. 1975;359(3):231–251.
110. Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 1988;2(10):2557–2568.
111. Morimoto Y, Durante W, Lancaster DG, Klattenhoff J, Tittel FK. Real-time measurements of endogenous CO production from vascular cells using an ultrasensitive laser sensor. Am J Physiol Heart Circ Physiol. 2001;280(1):H483–H488.
112. Mentré P, Escaig F. Preservation of the diffusible cations for secondary ion mass spectrometry. II. Artefacts in material embedded in araldite or melamine. Biol Cell. 1992;74(1):119–126.
113. Leffler CW, Balabanova L, Fedinec AL, Parfenova H. Nitric oxide increases carbon monoxide production by piglet cerebral microvessels. Am J Physiol Heart Circ Physiol. 2005;289(4):H1442–H1447.
114. Nathanson JA, Scavone C, Scanlon C, McKee M. The cellular Na+ pump as a site of action for carbon monoxide and glutamate: a mechanism for long-term modulation of cellular activity. Neuron. 1995;14(4):781–794.
115. Sohlenius-Sternbeck AK. Determination of the hepatocellularity number for human, dog, rabbit, rat and mouse livers from protein concentration measurements. Toxicol In Vitro. 2006;20(8):1582–1586.
116. Iwatsubo T, Suzuki H, Sugiyama Y. Prediction of species differences (rats, dogs, humans) in the in vivo metabolic clearance of YM796 by the liver from in vitro data. J Pharmacol Exp Ther. 1997;283(2):462–469.